The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors

被引:23
|
作者
Robinett, R. Graham
Freemerman, Alex J.
Skinner, Michael A.
Shewchuk, Lisa
Lackey, Karen
机构
[1] GlaxoSmithKline Inc, Mol Discovery Res Chem, Res Triangle Pk, NC 27709 USA
[2] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
关键词
c-src; RET; kinase inhibitors; 4-anilinoquinolines;
D O I
10.1016/j.bmcl.2007.07.104
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Substituted 4-(3-hydroxyanilino)-quinoline compounds, initially identified as small-molecule inhibitors of src family kinases, have been evaluated as potential inhibitors of RET kinase. Three compounds, 38, 31, and 40, had K-i's of 3, 25, and 50 nM in an in vitro kinase assay; while a cell based kinase assay showed Ki's of 300, 100, and 45 nM, respectively. These compounds represent potential new leads for the treatment of medullary and papillary thyroid cancer. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5886 / 5893
页数:8
相关论文
共 50 条
  • [1] The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity
    Newton, Rebecca
    Bowler, Katherine A.
    Burns, Emily M.
    Chapman, Philip J.
    Fairweather, Emma E.
    Fritzl, Samantha J. R.
    Goldberg, Kristin M.
    Hamilton, Niall M.
    Holt, Sarah V.
    Hopkins, Gemma V.
    Jones, Stuart D.
    Jordan, Allan M.
    Lyons, Amanda J.
    March, H. Nikki
    McDonald, Neil Q.
    Maguire, Laura A.
    Mould, Daniel P.
    Purkiss, Andrew G.
    Small, Helen F.
    Stowell, Alexandra I. J.
    Thomson, Graeme J.
    Waddell, Ian D.
    Waszkowycz, Bohdan
    Watson, Amanda J.
    Ogilvie, Donald J.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 112 : 20 - 32
  • [2] 4-[(3-Hydroxyanilino)(phenyl) methylidene]-3-methyl-1-phenyl-1H-pyrazol5(4H)-one
    Saida, Keraghel
    Fatiha, Benghanem
    Ouarda, Dehbi
    Ali, Ourari
    Kamela, Ouari
    Brelot, Lydia
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1909 - +
  • [3] Discovery of Substituted 4-(Pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as Potent and Highly Selective Rho Kinase (ROCK-II) Inhibitors
    Feng, Yangbo
    Yin, Yan
    Weiser, Arniee
    Griffin, Evelyn
    Cameron, Michael D.
    Lin, Li
    Ruiz, Claudia
    Schuerer, Stephan C.
    Inoue, Toshihiro
    Rao, P. Vasanth
    Schroeter, Thomas
    LoGrasso, Philip
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) : 6642 - 6645
  • [4] Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl) nicotinonitrile scaffold
    Brandt, Wiebke
    Mologni, Luca
    Preu, Lutz
    Lemcke, Thomas
    Gambacorti-Passerini, Carlo
    Kunick, Conrad
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (07) : 2919 - 2927
  • [5] Discovery of potent and specific FLT3 kinase inhibitors.
    Patel, HK
    Milanov, ZV
    Mehta, SA
    Grolzfeld, RM
    Lai, AG
    Fabian, MA
    Carter, TA
    Edeen, PT
    Velasco, AM
    Ford, JM
    Ciceri, P
    Insko, DE
    Floyd, M
    Herrgard, S
    Atteridge, CE
    Wodicka, LM
    Biggs, WH
    Treiber, DK
    Zarrinkar, PP
    Lockhart, DJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U128 - U129
  • [6] 4-anilino-3-cyanobenzo[g]quinolines as kinase inhibitors
    Zhang, N
    Wu, BQ
    Wissner, A
    Powell, DW
    Rabindran, SK
    Kohler, C
    Boschelli, F
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (03) : 423 - 425
  • [7] Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors
    Yang, Fang
    He, Cai-Ping
    Diao, Peng-Cheng
    Hong, Kwon Ho
    Rao, Jin-Jun
    Zhao, Pei-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (01) : 22 - 27
  • [8] Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase
    Selness, Shaun R.
    Devraj, Rajesh V.
    Monahan, Joseph B.
    Boehm, Terri L.
    Walker, John K.
    Devadas, Balekudru
    Durley, Richard C.
    Kurumbail, Ravi
    Shieh, Huey
    Xing, Li
    Hepperle, Michael
    Rucker, Paul V.
    Jerome, Kevin D.
    Benson, Alan G.
    Marrufo, Laura D.
    Madsen, Heather M.
    Hitchcock, Jeff
    Owen, Tom J.
    Christie, Lance
    Promo, Michele A.
    Hickory, Brian S.
    Alvira, Edgardo
    Naing, Win
    Blevis-Bal, Radhika
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5851 - 5856
  • [9] Discovery of the Potent Phosphoinositide 3-Kinase δ (PI3 K δ) Inhibitors
    Lei, Tao
    Hong, Yongwei
    Chang, Xinyue
    Zhang, Zhimin
    Liu, Xingguo
    Hu, Miao
    Huang, Wenhai
    Yang, Haiyan
    CHEMISTRYSELECT, 2020, 5 (01): : 196 - 200
  • [10] Discovery of 3,5-diaryl-1H-pyrazol-based ureas as potent RET inhibitors
    Wu, Kaifu
    He, Rui
    Li, Zongyang
    Qiu, Kongxi
    Xiao, Guorong
    Peng, Lijie
    Meng, Xiangbao
    Zheng, Canhui
    Zhang, Zhang
    Cai, Qian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 251